Reduction of blood loss in pediatric osteotomies around the hip - A randomized placebo-controlled trial with tranexamic acid

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516324-34-01

Enrollment

180

Registered

2024-11-21

Start date

2023-04-17

Completion date

Unknown

Last updated

2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental dysplasia of the hip (DDH), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Slipped capital femoral epiphysis (SCFE)

Brief summary

Estimated intraoperative blood loss (ml/kg)

Detailed description

Baseline demographic data, Indication for surgery, Prior surgery at same site, Treatment characteristics, Operative time, Eventual additional antifibrinolytic agents administered during surgery (including TXA), Blood transfusions, Pre- and postoperative blood values, including Hb, Complications, Duration of hospital stay

Interventions

DRUGSALINE

DRUGTRANEXAMIC ACID

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Design outcomes

Primary

Measure	Time frame
Estimated intraoperative blood loss (ml/kg)	—

Secondary

Measure	Time frame
Baseline demographic data, Indication for surgery, Prior surgery at same site, Treatment characteristics, Operative time, Eventual additional antifibrinolytic agents administered during surgery (including TXA), Blood transfusions, Pre- and postoperative blood values, including Hb, Complications, Duration of hospital stay	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026